Latest K-V Pharmaceutical Co. Cl B (KVPBQ) Headlin
Post# of 2
Posted On: 03/10/2014 9:51:08 AM
Latest K-V Pharmaceutical Co. Cl B (KVPBQ) Headlines
Ther-Rx Corporation Announces the Availability of Clindesse® (Clindamycin Phosphate) Vaginal Cream, 2% for Prescribing
PR Newswire - Mon Aug 05, 8:50AM CDT
Ther-Rx Corporation, a women's health-focused pharmaceutical company and subsidiary of K-V Pharmaceutical Company (OTCQB Marketplace: KVPHQ/KVPBQ) announced today that Clindesse® (clindamycin phosphate) Vaginal Cream, 2% indicated for the treatment of bacterial vaginosis (BV) in non-pregnant women, is now available for prescribing. Wholesalers have ordered and received product and are distributing to retail pharmacies.
K-V Pharma says Hologic settlement approved
AP - Fri Dec 28, 12:30PM CST
ST. LOUIS (AP) — A settlement between K-V Pharmaceutical Co. and Hologic has been approved by a bankruptcy court.
K-V Pharmaceutical Receives Court Approval of Hologic Settlement
PR Newswire - Fri Dec 28, 11:43AM CST
K-V Pharmaceutical Company ("K-V" or "the Company") today announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the Company's settlement agreement with Hologic, Inc. ("Hologic Settlement"), and authorized the Company to enter into an $85 million debtor-in-possession ("DIP") financing to, among other things, fund the settlement.
Ther-Rx Corporation Announces the Availability of Clindesse® (Clindamycin Phosphate) Vaginal Cream, 2% for Prescribing
PR Newswire - Mon Aug 05, 8:50AM CDT
Ther-Rx Corporation, a women's health-focused pharmaceutical company and subsidiary of K-V Pharmaceutical Company (OTCQB Marketplace: KVPHQ/KVPBQ) announced today that Clindesse® (clindamycin phosphate) Vaginal Cream, 2% indicated for the treatment of bacterial vaginosis (BV) in non-pregnant women, is now available for prescribing. Wholesalers have ordered and received product and are distributing to retail pharmacies.
K-V Pharma says Hologic settlement approved
AP - Fri Dec 28, 12:30PM CST
ST. LOUIS (AP) — A settlement between K-V Pharmaceutical Co. and Hologic has been approved by a bankruptcy court.
K-V Pharmaceutical Receives Court Approval of Hologic Settlement
PR Newswire - Fri Dec 28, 11:43AM CST
K-V Pharmaceutical Company ("K-V" or "the Company") today announced that the U. S. Bankruptcy Court for the Southern District of New York, the Honorable Judge Allan L. Gropper presiding, approved the Company's settlement agreement with Hologic, Inc. ("Hologic Settlement"), and authorized the Company to enter into an $85 million debtor-in-possession ("DIP") financing to, among other things, fund the settlement.
(0)
(0)K-V Pharmaceutical Company. (KVPBQ) Stock Research Links
Scroll down for more posts ▼